Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.

Posted on by

CONCLUSIONS: Treatment with higher doses of buprenorphine/naloxone was associated with a longer time to treatment discontinuation, less resource use, and lower total medical costs despite higher pharmacy acquisition cost.
PMID: 25295655 [PubMed – in process] (Source: Postgraduate Medicine)

MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…